Navigation Links
Angiotech announces intent to file 510(k) for its innovative 5-FU Central Venous Catheter (CVC) based on positive results from pivotal trial
Date:10/9/2007

VANCOUVER, Oct. 9 /PRNewswire-FirstCall/ - Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP), a global specialty pharmaceutical and medical device company, today announced that it intends to file Premarket Notification 510(k) documents with the U.S. Food and Drug Administration (FDA) for its innovative, anti-infective 5-Fluorouracil-coated (5-FU) Central Venous Catheter (CVC).

"After reviewing the data from our recently completed clinical trial, we are extremely pleased that the 5-FU CVC pivotal study has hit its primary efficacy endpoint while showing an excellent safety profile. We are looking forward to presenting the full data set in a scientific symposium at the upcoming Critical Care Congress in February," said Dr. William Hunter, President and CEO of Angiotech.

"Based on the positive results from the U.S. pivotal trial, we will prepare a 510(k) package, which we expect to submit to the FDA in the fourth quarter of 2007. This is another important step towards commercializing our 5-FU CVC product line and our 5-FU anti-infective platform," continued Dr. Hunter.

"This is an exciting milestone for Angiotech. Our R&D efforts are striving to address two of the most common problems in surgery and medical devices: restenosis following vascular injury and infection related to medical device implantation. We continue to work towards achieving success in one of the most challenging areas of medical device development by deriving new and useful applications for our leading drug platforms, paclitaxel and 5-FU, and taking them from their early stages in the lab to their actual clinical use," added Dr. Jeff Walker, Senior VP, Research and Development for Angiotech.

The 5-FU CVC is expected to be
'/>"/>

SOURCE Angiotech Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., , LIBREVILLE, Gabon, December 2 /PRNe...n Africa: Everyone,s Problem and Heritage" , ...iversity, 2-3 June 2010 the,Gabonese Republic is h...Gabon) on the issue of safeguarding biological res...by government and state leaders, ministers,scient...
(Date:12/2/2009)..., , CAMBRIDGE, Mass., Dec. 2 /PRNewswi...er the leaders in technology development and produ... MEMS, announced the December 11th deadline for te..., Now in its 14th year, TechConnect World, in ass...itute (NSTI), and the Clean Technology and Sustain...
(Date:12/2/2009)..., , SINGAPORE, Dec. 2 ...n its novel oral JAK2 inhibitor, SB1518, at The Am...nd Exposition in New Orleans. ,, Data will be p...dose-escalation trial of SB1518 detailing its safe...ic (PK/PD) profile in dose levels ranging from 100...
(Date:12/2/2009)..., , NANJING, China, Dec. 2 /PRNewswir... or the "Company") (NYSE: SCR ), a leading pharm... manufacturing, and marketing of branded,generic a...ounced that 105 of,its drugs have been included in..., which was issued by China,s Ministry of Human Re...
Breaking Biology Technology:Libreville International Conference 2-3 June 2010 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3
... large quantities of difficult-to-express proteins... ,Biochemical & Molecular Allergology, Research ...L21-CodonPlus(DE3)-RIL cells * with,extra copies... is possible to attain high-level expression of di...PTG-induced expression of several recombinant pean...
...embryonic cell lines are useful for in vitro mutag...atagene Cloning Systems, Inc. , The Big Blue rat...onic,cell line are useful for in vitro mutagenes... Blue transgenic rodent mutagenesis assay system,*...nown mutagens in a variety of tissues from,trans...
... for neuroscience research , , , Danny Q. ...gerelli ,Stratagene Cloning Systems, Inc. , ,...es for NMDA receptor,subunits that are useful fo...,subunit proteins in different cell types and brai...stern blot analysis of rat brain to study expressi...
Other Biology Technology:High-Level Expression of Peanut Allergens Affected by Rare Codon Usage 2High-Level Expression of Peanut Allergens Affected by Rare Codon Usage 3High-Level Expression of Peanut Allergens Affected by Rare Codon Usage 4Big Blue Rodent Cell Cultures for Mutagenesis Studies 2Antibodies for Studying NMDA Receptor Protein Expression and,Synapse-Specific Immunolabeling 2Antibodies for Studying NMDA Receptor Protein Expression and,Synapse-Specific Immunolabeling 3Antibodies for Studying NMDA Receptor Protein Expression and,Synapse-Specific Immunolabeling 4
(Date:12/2/2009)...ent at the University of Southampton,s School of O...nography Centre, Southampton (NOCS) has formally d...he deep sea. , Hall discovered the new species i...um of Natural History in Washington. Explaining th...include some of the largest crustaceans currently ...
(Date:12/1/2009)...s National Primate Research Center, Emory Universi...ic prairie voles, an important step toward unlocki...e application of this technology will enable scien...hat will help identify the brain mechanisms of soc...is advancement may also have important implication...
(Date:12/1/2009)...r,s disease, nerve cell degeneration plays a cruci...y possibly be derived from steering the generation...een published in the current issue of the renowned...ears ago, neurogenesis the process of nerve cell ...e adult brain. The textbooks asserted that dead ne...
Breaking Biology News(10 mins):King crab family bigger than ever 2Yerkes researchers create first transgenic prairie voles 2New source discovered for the generation of nerve cells in the brain 2Revolutionizing the diagnosis of serious disease 47651 1Revolutionizing the diagnosis of serious disease 47651 2Journal of Periodontology and the American Journal of Cardiology develop joint clinical recommendations 47649 1Journal of Periodontology and the American Journal of Cardiology develop joint clinical recommendations 47649 2Journal of Periodontology and the American Journal of Cardiology develop joint clinical recommendations 47649 3Make Sure Your Baby is Seeing the Most Important Things in His World 47647 1Make Sure Your Baby is Seeing the Most Important Things in His World 47647 2Make Sure Your Baby is Seeing the Most Important Things in His World 47647 3Make Sure Your Baby is Seeing the Most Important Things in His World 47647 4Make Sure Your Baby is Seeing the Most Important Things in His World 47647 5
...D, a specialist in neural tissue engineering, has ...velopment Award by the National Science Foundation...f biomedical engineering at NJIT,s Newark College ...expand his research into rapid axon stretch growth... nerve cells. , In collaboration with a team of s...
...uld serve the UK for a year and oil reserves would...if efficiency in the car industry had improved at ... computer scientist will tell an audience in Manch...urber CBE, ICL Professor of Computer Engineering a...naugural Kilburn Lecture to mark Digital 60 Day t...
...ailable in French . , Montreal, 19 June 2008 S...patients to lose up to 70 percent of their excess ...dy by Dr. Nicolas Christou of the McGill Universit... that this surgery also decreases the risk of deve...esented his preliminary results yesterday at the 2...
Other Biology News:NJIT biomedical engineer receives NSF Career Development Award 2Liter of fuel would last UK 1 year if cars had kept pace with computers 2Weight-loss surgery can cut cancer risk 2
...e spatulas have been designed to save time and pro...e interested in eliminating the recycling and rest...patula is individually packaged, RNase/DNase free,...umber is a new product number, created to easily m...
...e spatulas have been designed to save time and pro...e interested in eliminating the recycling and rest...patula is individually packaged, RNase/DNase free,...umber is a new product number, created to easily m...
...e Phosphatase Detection Kit (Catalog number SCR004...pic assessment of ES cell differentiation by the d... from CHEMICON are the monoclonal antibodies TRA-2... Number MAB4354), which permit the detection of Li...
Complete 2 channel polarographic oxygen monitoring system from Instech Solomon
Biology Products: